GTPase Inhibitors
Learn MoreVCP-p97 inhibitors are a class of compounds that target a key enzyme involved in cellular protein degradation By inhibiting the activity of VCP-p97 these inhibitors disrupt the protein quality control system within cells leading to the accumulation of misfolded or damaged proteins This targeted disruption offers potential therapeutic benefits in the treatment of diseases such as cancer and neurodegenerative disorders where abnormal protein aggregation is a key feature Our company offers a range of highly potent VCP-p97 inhibitors that can be used in preclinical and clinical research to explore the therapeutic potential of targeting this enzyme
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
EI-0531 | CB5083 | 1542705-92-9 | Online Inquiry |
EI-0715 | DBeQ | 177355-84-9 | Online Inquiry |
EI-0787 | Eeyarestatin I | 412960-54-4 | Online Inquiry |
EI-1424 | MDBN | 1485-00-3 | Online Inquiry |
EI-1485 | ML-240 | 1346527-98-7 | Online Inquiry |
EI-1578 | NMS-873 | 1418013-75-8 | Online Inquiry |
VCP-p97 inhibitors have a wide range of applications in both research and medicine In the field of research these inhibitors are commonly used to study the role of VCP-p97 in cellular processes and pathways By inhibiting the activity of VCP-p97 scientists can gain a better understanding of how this protein contributes to protein degradation DNA repair and cell signaling
In medicine VCP-p97 inhibitors show promise as potential therapeutics for various diseases For example studies have shown that VCP-p97 inhibitors can disrupt the function of cancer cells and promote their death making them potential candidates for cancer treatment Additionally these inhibitors have shown potential in neurodegenerative diseases as they can help clear abnormal protein aggregates that are associated with conditions such as Alzheimer's and Parkinson's disease
Furthermore VCP-p97 inhibitors can also be used to enhance the efficacy of chemotherapy drugs By inhibiting the activity of VCP-p97 these inhibitors can prevent cancer cells from developing resistance to chemotherapy thereby improving the overall effectiveness of the treatment
Overall VCP-p97 inhibitors have versatile applications in both research and medicine offering potential advancements in understanding cellular processes and developing new therapeutic strategies
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.